Clinical and immunological characterization of systemic lupus erythematosus in patients with circulating interferon and migration inhibitory factor.
The simultaneous occurrence of interferon and migration inhibitory factor was found in sera from 9 patients with systemic lupus erythematosus (SLE). Their clinical picture was characterized by a moderate course of the disease. In 7 patients the inflammatory tendoarticular manifestations were accentuated. Glomerulonephritis was found only in 3 patients and was successfully suppressed by immunosuppressive therapy. In the peripheral blood of most of these patients, normal or moderately increased levels of active E-rosettes were found. Therefore we consider these SLE patients as a group with characteristic signs of activated cell-mediated immunity (lymphokine release, active E-rosettes). Although the reason for this activation remains unknown, we suppose that some concomitant bacterial infection, perhaps mycobacterial, may contribute to this immunological phenomenon.
D000328:Adult; D005260:Female; D005921:Glomerulonephritis / Q000276:immunology; D006680:HLA Antigens / Q000032:analysis; D006801:Humans; D007372:Interferons / Q000097:blood*; D007961:Leukocyte Migration-Inhibitory Factors / Q000097:blood*; D008180:Lupus Erythematosus, Systemic / Q000097:blood / Q000276:immunology*; D008222:Lymphokines / Q000097:blood*; D008297:Male; D008875:Middle Aged; D012397:Rosette Formation
D006680:HLA Antigens; D007961:Leukocyte Migration-Inhibitory Factors; D008222:Lymphokines; D007372:Interferons